Novo Nordisk chair and directors quit after boardroom rift

Novo Nordisk's Canadian Mistake

Logitech Open To Adding an AI Agent To Board of Directors, CEO Says

Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee